COPARIME: Pilot Study of a Target Detection of Malignant Melanoma
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Patients at Risk for Melanoma
Both
Patients at Risk for Melanoma
Trial Information
COPARIME: Pilot Study of a Target Detection of Malignant Melanoma
Inclusion Criteria:
- patients more than 18 years old,
- consulting their GP,
- assessed at risk for melanoma according to the SAMScore
- signed the consent.
Type of Study:
Interventional
Study Design:
Intervention Model: Single Group Assignment, Masking: Open Label
Outcome Measure:
Prevalence ratios between those of the COPARIME cohort and those of the general population.
Outcome Description:
Number of melanomas detected / Number of patients at high risk of melanoma defined by our selection tool.
Outcome Time Frame:
5 years
Safety Issue:
No
Principal Investigator
Jean-Michel NGUYEN, Doctor
Investigator Role:
Study Chair
Investigator Affiliation:
Nantes University Hospital
Authority:
France: Agence Nationale de Sécurité du Médicament et des produits de santé
Study ID:
10/11-N
NCT ID:
NCT01610531
Start Date:
April 2011
Completion Date:
April 2020
Related Keywords:
- Patients at Risk for Melanoma
- Cohort
- Melanoma
- targeted screening
- risks function
- cost effectiveness
- Melanoma
Name | Location |
|---|
